Cargando…
CEACAM1 Activation by CbpF-Expressing E. coli
Recent studies on the oral, anaerobic, gram-negative bacterium Fusobacterium nucleatum revealed its presence and involvement in colorectal, esophageal and breast cancer. We previously demonstrated that F. nucleatum binds and activates the human inhibitory receptors TIGIT and CEACAM1 leading to inhib...
Autores principales: | Shhadeh, Amjad, Galaski, Johanna, Alon-Maimon, Tamar, Fahoum, Jamal, Wiener, Reuven, Slade, Daniel J., Mandelboim, Ofer, Bachrach, Gilad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358318/ https://www.ncbi.nlm.nih.gov/pubmed/34395310 http://dx.doi.org/10.3389/fcimb.2021.699015 |
Ejemplares similares
-
Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation
por: Galaski, Johanna, et al.
Publicado: (2021) -
Fusobacterium spp. target human CEACAM1 via the trimeric autotransporter adhesin CbpF
por: Brewer, Matthew L., et al.
Publicado: (2019) -
Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022) -
High mannose level in bladder cancer enhances type 1 fimbria–mediated attachment of uropathogenic E. coli
por: Maalouf, Naseem, et al.
Publicado: (2022) -
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System
por: Abed, Jawad, et al.
Publicado: (2020)